Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary

Highlights ► Ovarian small-cell carcinoma of the hypercalcemic type is a rare neoplasm with no standard treatment. ► The chemotherapy regimen including vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin and etoposide (VPCBAE) has limited toxicities and was effective in the 3 patients d...

Full description

Saved in:
Bibliographic Details
Published inGynecologic oncology case reports Vol. 2; no. 2; pp. 58 - 60
Main Authors Wallbillich, John J, Nick, Alpa M, Ramirez, Pedro T, Watkins, Jack L, Euscher, Elizabeth D, Schmeler, Kathleen M
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 2012
Elsevier
Subjects
Case Report
Chemotherapy
Hematology, Oncology and Palliative Medicine
Obstetrics and Gynecology
Ovarian cancer
Small cell
Small cell
Chemotherapy
Ovarian cancer
Online AccessGet full text

Cover

More Information
Summary:Highlights ► Ovarian small-cell carcinoma of the hypercalcemic type is a rare neoplasm with no standard treatment. ► The chemotherapy regimen including vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin and etoposide (VPCBAE) has limited toxicities and was effective in the 3 patients described in this case report.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2211-338X
2211-338X
DOI:10.1016/j.gynor.2012.02.001